The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of HER2 amplification in the primary tumor to predict presence of circulating tumor cells in inflammatory breast cancer.
A. Bhattacharyya
No relevant relationships to disclose
S. Krishnamurthy
No relevant relationships to disclose
A. Lodhi
No relevant relationships to disclose
C. Hall
No relevant relationships to disclose
A. Anderson
No relevant relationships to disclose
H. M. Kuerer
No relevant relationships to disclose
I. Bedrosian
No relevant relationships to disclose
R. H. Alvarez
No relevant relationships to disclose
N. T. Ueno
No relevant relationships to disclose
S. Jackson
No relevant relationships to disclose
B. Singh
No relevant relationships to disclose
A. Lucci
No relevant relationships to disclose